Toggle Nav
Advanced Search
My Cart

Shop by Category

View all Hematology titles
Winter Sale. Save up to thirty-five percent off books, eBooks, and subscriptions.Winter Sale. Save up to thirty-five percent off books, eBooks, and subscriptions.

New Drugs for Malignancy, An Issue of Hematology/Oncology Clinics of North America, 1st Edition

Author :
Franco Muggia
Topics in this issue include: Targeting IGF-1R; Tyrosine Kinase Inhibitors in Lung Cancer; Targeting mTOR; Targeting Hedgehog; Mitotic Inhibitors; Topoisomerase I Inhibitors; and New Strategies and Drugs Inhibiting Folate Pathways.
Be the first to review this product
printebook
Special Price $74.24 $98.99
printebook
Special Price $74.24 $98.99
Add to Cart
Add to Cart
Subscription Options
Add to Wish List
PRINT ON DEMAND - DELIVERY CAN TAKE UP TO 10 DAYS
25% OFF
main product photo
Topics in this issue include: Targeting IGF-1R; Tyrosine Kinase Inhibitors in Lung Cancer; Targeting mTOR; Targeting Hedgehog; Mitotic Inhibitors; Topoisomerase I Inhibitors; and New Strategies and Drugs Inhibiting Folate Pathways.

Author Information
By Franco Muggia, MD

* Elsevier is a leading publisher of health science books and journals, helping to advance medicine by delivering superior education, reference information and decision support tools to doctors, nurses, health practitioners and students. With titles available across a variety of media, we are able to supply the information you need in the most convenient format.



Copyright © 2025, its licensors, and contributors.

All rights are reserved, including those for text and data mining, AI training, and similar technologies.

For problems or suggestions regarding this site, please visit our Support Hub.

RELX Group